Humacyte, Inc. HUMA
Nasdaq · XNAS · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2020-09-22
Humacyte, Inc. institutional holders (13F)
| Investor | Shares | Value |
|---|---|---|
| BlackRock Finance, Inc. | 7,140,014 | $34.3M |
| AQR CAPITAL MANAGEMENT LLC | 1,924,691 | $1.2M |
| CITADEL ADVISORS LLC | 396,000 | $240,253 |
| TWO SIGMA INVESTMENTS, LP | 177,536 | $107,711 |
| MILLENNIUM MANAGEMENT LLC | 170,654 | $71,329 |
Source: SEC EDGAR filings · CIK 0001818382 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.